Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Evaluation of the Health-related Quality of Life, Psychological Distress and Fatigue in Metastatic Castration-resistant Prostate Cancer Patients Treated With Radium-223 Therapy, a Multicenter, Prospective Observational Cohort Study

NCT04995614 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT04995614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04995614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Evaluation of the Health-related Quality of Life, Psychological Distress and Fatigue in Metastatic Castration-resistant Prostate Cancer Patients Treated With Radium-223 Therapy, a Multicenter, Prospective Observational Cohort Study
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Completed
Start date
April 1, 2017
Completion date
June 29, 2020
Enrollment
122 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, castrate resistant prostate cancer